	债务利息支出		日
Acadia Pharmaceuticals	USD 0	4.12M	2024-09
Adma Biologics	USD 1.63M	54K	2025-12
ALKERMES	USD 12.28M	7.63M	2025-12
AstraZeneca	USD 484M	181M	2025-12
BioCryst Pharmaceuticals	USD 14.14M	5.53M	2025-12
Bristol-Myers Squibb	USD 432M	48M	2025-12
Cipla	INR 140.3M	8.5M	2025-12
Compugen	USD 954K	116K	2025-09
CSL	USD 215M	111M	2025-12
Eli Lilly	USD 114.7M	134.3M	2025-09
Esperion Therapeutics	USD 22.64M	585K	2025-12
GlaxoSmithKline	GBP 188M	21M	2025-12
Grifols	EUR 156.07M	31.46M	2025-09
Halozyme Therapeutics	USD 4.91M	615K	2025-12
Ionis Pharmaceuticals	USD 18M	0	2025-12
J&J	USD 18M	290M	2025-09
Merck	USD 412M	85M	2025-12
Minerva Neurosciences	USD 2.31M	60K	2024-06
Neurocrine Biosciences	USD 1.1M	0	2024-03
Novartis	USD 304M	23M	2025-12
Novavax	USD 5.82M	342K	2025-12
Pfizer	USD 711M	59M	2025-12
Roche Holding	CHF 304M	7.5M	2025-06
Sanofi	EUR -25M	252M	2025-12
Takeda	JPY 123.63B	40.49B	2025-12
Vanda Pharmaceuticals	601.14M	23.61M	2025-09